{"id":35406,"date":"2024-05-22T12:03:10","date_gmt":"2024-05-22T10:03:10","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/?p=35406"},"modified":"2024-05-16T14:25:08","modified_gmt":"2024-05-16T12:25:08","slug":"erratum-8","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2024\/erratum-8","title":{"rendered":"Erratum"},"content":{"rendered":"<p>In unserer Kleinen Mitteilung zu neuen Therapieformen bei der prim\u00e4ren bili\u00e4ren Cholangitis (AMB 2024, 58, 30) wurden die beiden besprochenen Studien im vorletzten Absatz leider verwechselt. Es muss korrekt hei\u00dfen: \u201eWarum der Juckreiz in der RESPONSE-Studie, nicht aber in der ELATIVE-Studie g\u00fcnstig beeinflusst wurde, bleibt unklar.\u201c<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In unserer Kleinen Mitteilung zu neuen Therapieformen bei der prim\u00e4ren bili\u00e4ren Cholangitis (AMB 2024, 58, 30) wurden die beiden besprochenen Studien im vorletzten Absatz leider verwechselt. Es muss korrekt hei\u00dfen: \u201eWarum der Juckreiz in der RESPONSE-Studie, nicht aber in der ELATIVE-Studie g\u00fcnstig beeinflusst wurde, bleibt unklar.\u201c<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[5995,5996,4982,5994,4693],"class_list":["post-35406","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-biliaere-cholangitis","tag-elative-studie","tag-erratum","tag-primaere-biliaere-cholangitis","tag-response-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/35406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=35406"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/35406\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=35406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=35406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=35406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}